Yale Center for Immuno-Oncology
The Yale Center for Immuno-Oncology was established in 2018 to build on Yale Cancer Center’s international leadership in immunology, immunobiology, and the development of innovative cancer immunotherapies. The Center is a partnership between Yale Cancer Center and the Department of Immunobiology at Yale School of Medicine.
The goals for the Yale Center for Immuno-Oncology (YCIO) include to:
- Leverage Yale leadership in immunobiology and immunotherapy drug development.
- Develop the next generation of immune-based therapies.
- Genetically engineer immune cells to target a patient’s cancer (cell therapies).
“This new center gives us the chance to work more collaboratively and efficiently with our world-renowned scientists and faculty to address scientific questions in Immuno-Oncology,” said Marcus Bosenberg, MD, PhD, Professor of Dermatology, Pathology, and Immunobiology, and interim director of YCIO.
